Oncolipsy kits are high-throughput PCR-based assays that are used for downstream analysis of nucleic acids including DNA mutations or mRNA expression transcripts, providing rapid and accurate results in tumor and liquid biopsy material. CTC molecular characterization requires assays with high sensitivity and specificity to be used as diagnostic tools for detecting druggable biomarkers, aiding treatment decisions in the clinical setting.

Oncolipsy kits offer